AARD · Aardvark Therapeutics, Inc. · Proposed Sales
Market Cap
$84.91M
Shares
21.88M
Volume · Oct 20
66.71K
Avg daily vol (3M)
129.68K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-09-11 | NELSON SUN | Officer | 33,911 | 2026-09-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-10 | NELSON SUN | Officer | 42,843 | 2026-09-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-15 | VICKERS VENT GLB DEEP-TECH FND I LP | Director, 10% Stockholder | 10,360 | 2025-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-02 | VICKERS VENT GLB DEEP-TECH FND I LP | Director, 10% Stockholder | 20,000 | 2025-09-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-08-28 | VICKERS VENT GLB DEEP-TECH FND I LP | Director, 10% Stockholder | 27,691 | 2025-08-28 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–5 of 5 filings